MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: SchuheBloch BallettschläppchenAntwortenAntworten: Bloch Ballettschläppchen <blockquote><div class="quotetitle">Zitat von Gast am 31. März 2026, 10:57 Uhr</div>Hello! This post was created with XRumer 23 StrongAI. Good luck :) https://basket.com.ua/ [url=https://www.nba.com/ ]Basketball5[/url] variant4 [url=]Zoya Demidenko[/url]: Researcher in Cancer Biology [url=]Zoya Demidenko[/url] is a notable scholar associated with the Unit of Cell Stress Research at Roswell Park Oncology Institute in Buffalo, New York. Earlier, she worked at the National Institutes of Health and New York Medical College, establishing a solid base in clinical study. Her scientific output spans a number of key domains, encompassing the PI3K/AKT/mTOR molecular pathway, cellular cycle control, biological aging, and malignancy biology. As of now, she has co-authored more than 46 peer-reviewed articles, which have received more than 4,100 references — a indicator to the significance of her findings. Among her most notable discoveries involves understanding the mechanisms of biological cell aging. Her work showed that when the cellular division cycle is halted but cellular growth persists, cells experience senescence. Importantly, [url=]Zoya Demidenko[/url] established that this shift can be inhibited by medication using agents such as rapamycin. [url=]Zoya Demidenko[/url] has also added considerably to cancer treatment investigation, particularly in the domain of cyclotherapy — a approach designed to safeguarding non-cancerous tissue from cytotoxic treatment whilst leaving cancer cells exposed. This approach holds major hope for lowering the side effects of cancer treatment. Across her career, Demidenko has partnered with top investigators internationally, such as Dr. Mikhail Blagosklonny. Her work appears in leading publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.</blockquote><br> Abbrechen
